AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The ...

Read More »

AstraZeneca to Shift U.S. Trading Venue to NYSE, Strengthening Global Investor Access

AstraZeneca PLC (LON:AZN) announced plans to transfer its U.S. trading venue from Nasdaq to the New York Stock Exchange (NYSE), a move designed to broaden access to global investors and enhance ...

Read More »

How will AI impact the pharma industry?

The potential of AI to analyse vast quantities of data in a relatively short time frame makes its application to the pharmaceutical industry, particularly the time- and cost-intensive process of drug ...

Read More »

Astrazeneca (AZN) stock slides as market rises: Facts to know before you trade

Astrazeneca (AZN) ended the recent trading session at $76.28, demonstrating a -1.03% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.49 ...

Read More »

AstraZeneca says Fasenra misses main goal in COPD trial

In a separate announcement on Wednesday, AstraZeneca reported positive late-stage results for its lupus therapy Saphnelo. The company said the TULIP-SC Phase III study of self-administered Saphnelo ...

Read More »